714 assets in Colorectal Cancer

Ametumumab

Amt-676

Artesunate

aur109

Bemalenograstim Alfa

bi 907828

Ciprofloxacin

dsp107

Eliglustat

Entrectinib

eo2040

Erfonrilimab

Fianlimab

Fluzoparib

Fulzerasib

Futibatinib

ibi363

Ibuprofen

Immunoglobulin G1, Anti-(Human Cytotoxic T-Lymphocyte-Associated Antigen 4) (Human-Mus Musculus Monoclonal M3 .Gamma.1-Chain), Disulfide With Human-Mus Musculus Monoclonal M3 .Kappa.-Chain, Dimer

Immunoglobulin G1, Anti-(Human Interleukin-1 Receptor Accessory Protein) (Human-Mus Musculus Monoclonal Can04 .Gamma.1-Chain), Disulfide With Human-Mus Musculus Monoclonal Can04 .Kappa.-Chain, Dimer

Immunoglobulin G1 [De-448-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mouse Monoclonal C225 ?1-Chain) Fusion Protein With Peptide Linker (Ggggs)2 Fusion Protein With Immunoglobulin Anti-(Human Epidermal Growth Factor Receptor Her3) (Human Clone Her3.H3 Single-Chain Variable Fragment Vh-(Ggggs)3-Vl), Complex With Human-Mouse Monoclonal C225 ?-Chain, Dimer, 214??,214???,222,222?,228,228?,231,231?-Octakis(Thioether) With (2S)-N-(Carboxymethyl)-2-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-?-Alanylglycylglycyl-L-Phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-1-Methyl-2-Oxoethoxy]Methyl]Glycinamide

Immunoglobulin Half-Ig G1-Kappa/Scfv-H-Ch2-Ch3, Anti-(Homo Sapiens Ctla4 (Cytotoxic T-Lymphocyte-Associated Protein 4, Cd152)) And Anti-(Homo Sapienspdcd1 (Programmed Cell Death 1, Pd-1, Pd1, Cd279)), Monoclonal Antibody, Bispecific

Imu-201 (Pd1-Vaxx)

Lenalidomide

Leronlimab

Lobaplatin

Losartan

Mirabegron

mk-4830

Naproxen

Navicixizumab

NC 410

Neoantigen Dendritic Cell Vaccine

Nocardia Rubra Cell Wall Skeleton

Pd-L1 T-Hank

Qbeco

Recombinant Mutant Human Tumor Necrosis Factor

Rilvegostomig

Romiplostim

Shr-3821

Si-B001

Si-B003

Spartalizumab

Temuterkib

Tovecimig

Tretinoin

Vibostolimab

Volrustomig

Cea Car-T Cells

Decoy20